Functional abnormalities underlying pathological gambling in parkinson disease

Archives of Neurology

Volumn 65, Issue 12, 2008, Pages 1604-1611

  Cilia, Roberto ^a,b   Siri, Chiara ^a   Marotta, Giorgio ^c   Isaias, Ioannis U ^a,b   De Gaspari, Danilo ^a   Canesi, Margherita ^a   Pezzoli, Gianni ^a   Antonini, Angelo ^a  

^a PARKINSON INSTITUTE   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; CARBIDOPA; CYSTEINE ETHYL ESTER TC 99M; DOPAMINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN PERFUSION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DATA ANALYSIS; FEMALE; GLOBUS PALLIDUS; HEMISPHERE; HIPPOCAMPUS; HUMAN; INSULA; LIMBIC SYSTEM; MALE; ORBITAL CORTEX; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; REWARD; RIGHT HANDEDNESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL PARAMETERS; TERTIARY HEALTH CARE;

AGED; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; CYSTEINE; FEMALE; FUNCTIONAL LATERALITY; GAMBLING; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 61449212993     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.12.1604     Document Type: Article

References (34)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006;63(7):969-973.
3. Voon V, Thomsen T, Miyasaki JM, et al. Factors associated with dopaminergic medication-related pathological gambling in Parkinson disease. Arch Neurol. 2007;64(2):212-216.
4. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry. 2005;58(10):787-795.
5. Isaias IU, Siri C, Cilia R, et al. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord. 2008;23(3):411-415.
6. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry. 2002;159(10):1642-1652.
7. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160(6):1041-1052.
8. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(suppl 1):3-13.
9. Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord. 2007;22(10):1430-1435.
10. Künig G, Leenders KL, Martin-Sölch C, Missimer J, Magyar S, Schultz W. Reduced reward processing in the brains of parkinsonian patients. Neuroreport. 2000;11(17):3681-3687.
11. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia. 2002;40(13):2257-2267.
12. Cools R. Dopaminergic modulation of cognitive function: implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev. 2006;30(1):1-23.
13. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42(6):1142-1146.
14. Lesieur HR, Blume SB. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987;144(9):1184-1188.
15. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000;68(4):423-428.
16. Cilia R, Marotta G, Landi A, et al. Cerebral activity modulation by extradural motor cortex stimulation in Parkinson's disease: a perfusion SPECT study. Eur J Neurol. 2008;15(1):22-28.
17. Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels forfunctional brain mapping. Hum Brain Mapp. 2000;10(3):120-131.
18. Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med. 2004;45(6):933-942.
19. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, SilberMH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology. 2007;68(4):301-303.
20. Beaver JD, Lawrence AD, van Ditzhuijzen J, Davis MH, Woods A, Calder AJ. Individual differences in reward drive predict neural responses to images of food. J Neurosci. 2006;26(19):5160-5166.
21. Cohen MX, Krohn-Grimberghe A, Elger CE, Weber B. Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci. 2007;26(12):3652-3660.
22. Holden C. "Behavioral" addictions: do they exist? Science. 2001;294(5544):980-982.
23. Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibanez A. Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry. 2001;6(3):167-176.
24. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(suppl 1):142-151.
25. Kwon JS, Kim JJ, Lee DW, et al. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res. 2003;122(1):37-47.
26. McClure SM, Laibson DI, Loewenstein G, Cohen JD. Separate neural systems value immediate and delayed monetary rewards. Science. 2004;306(5695):503-507.
27. Smith KS, Berridge KC. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci. 2007;27(7):1594-1605.
28. Sell LA, Morris JS, Bearn J, Frackowiak RS, Friston KJ, Dolan RJ. Neural responses associated with cue evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend. 2000;60(2):207-216.
29. Mesulam MM, Mufson EJ. Insula of the Old World monkey, I: architectonics in the insulo-orbito-temporal component of the paralimbic brain. J Comp Neurol. 1982;212(1):1-22.
30. Hodgins DC, el-Guebaly N. Retrospective and prospective reports of precipitants to relapse in pathological gambling. J Consult Clin Psychol. 2004;72(1):72-80.
31. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci. 2001;4(1):95-102.
32. Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation: an analysis of published case series. Mov Disord. 2007;22(12):1757-1763.
33. Munro CA, McCaul ME, Wong DF, et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry. 2006;59(10):966-974.
34. Hoeft F, Watson CL, Kesler SR, Bettinger KE, Reiss AL. Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res. 2008;42(4):253-258.